These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3400510)

  • 1. The predictive value of acute antimuscarinic drugs for the chronic efficacy of antimuscarinic drugs in adults with focal dystonia.
    Tanner CM; Wilson RS; Goetz CG; Shannon KM
    Adv Neurol; 1988; 50():557-60. PubMed ID: 3400510
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimuscarinic drugs in the treatment of movement disorders.
    Fahn S; Burke R; Stern Y
    Prog Brain Res; 1990; 84():389-97. PubMed ID: 2267310
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dosage anticholinergic therapy in dystonia.
    Fahn S
    Adv Neurol; 1983; 37():177-88. PubMed ID: 6134442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dystonia: therapy with high dosage anticholinergic medication.
    Reddy RV; Siemers ER
    Indiana Med; 1987 Jun; 80(6):552-3. PubMed ID: 2886522
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute pharmacologic tests in cranial dystonia.
    Giménez-Roldán S; Mateo D; Orbe M; Muñoz-Blanco JL; Hípola D
    Adv Neurol; 1988; 49():451-66. PubMed ID: 3344636
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of dystonia with high-dosage trihexyphenidyl].
    Hashimoto T; Shindo M; Yanagisawa N
    Rinsho Shinkeigaku; 1984 Aug; 24(8):769-77. PubMed ID: 6509822
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained-release anticholinergics in dystonia: case report.
    Samie MR
    Neurology; 1987 May; 37(5):885-6. PubMed ID: 3574699
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of trihexyphenidyl after short-term and long-term administration to dystonic patients.
    Burke RE; Fahn S
    Ann Neurol; 1985 Jul; 18(1):35-40. PubMed ID: 4037749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive processes in idiopathic dystonia treated with high-dose anticholinergic therapy: implications for treatment strategies.
    Taylor AE; Lang AE; Saint-Cyr JA; Riley DE; Ranawaya R
    Clin Neuropharmacol; 1991 Feb; 14(1):62-77. PubMed ID: 2029694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute anticholinergic action in focal dystonia.
    Lang AE; Sheehy MP; Marsden CD
    Adv Neurol; 1983; 37():193-200. PubMed ID: 6134443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic-induced chorea in the treatment of focal dystonia.
    Nomoto M; Thompson PD; Sheehy MP; Quinn NP; Marsden CD
    Mov Disord; 1987; 2(1):53-6. PubMed ID: 3504259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind evaluation of trihexyphenidyl in dystonia.
    Burke RE; Fahn S
    Adv Neurol; 1983; 37():189-92. PubMed ID: 6858772
    [No Abstract]   [Full Text] [Related]  

  • 13. Cranial dystonia: double-blind crossover study of anticholinergics.
    Nutt JG; Hammerstad JP; deGarmo P; Carter J
    Neurology; 1984 Feb; 34(2):215-7. PubMed ID: 6363970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with antiparkinsonian drugs with chronic psychiatric patients.
    Roy P; St-Jean A; Ban T; Noe W
    Int J Neuropsychiatry; 1966 Feb; 2(1):65-9. PubMed ID: 5907816
    [No Abstract]   [Full Text] [Related]  

  • 15. High dose anticholinergic therapy in adult dystonia.
    Lang AE
    Can J Neurol Sci; 1986 Feb; 13(1):42-6. PubMed ID: 2869832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy.
    Sanger TD; Bastian A; Brunstrom J; Damiano D; Delgado M; Dure L; Gaebler-Spira D; Hoon A; Mink JW; Sherman-Levine S; Welty LJ;
    J Child Neurol; 2007 May; 22(5):530-7. PubMed ID: 17690057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meige syndrome: treatment with trihexyphenidyl.
    Nutt JG; Hammerstad JP; Carter JH; deGarmo P
    Adv Neurol; 1983; 37():201-5. PubMed ID: 6344588
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiparkinsonism drugs.
    Med Lett Drugs Ther; 1965 Mar; 7(6):22-4. PubMed ID: 5831354
    [No Abstract]   [Full Text] [Related]  

  • 19. Do the neurochemical characteristics of fibroblasts in tissue culture predict the therapeutic drug response of dystonia patients?
    Richardson JS; Dunlop DM
    Adv Neurol; 1988; 50():187-92. PubMed ID: 3400493
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medical treatment of dystonia].
    Kachi T
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1181-2. PubMed ID: 12235832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.